These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 21109300

  • 1. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
    Chung HH, Kim JW, Han KH, Eo JS, Kang KW, Park NH, Song YS, Chung JK, Kang SB.
    Gynecol Oncol; 2011 Feb; 120(2):270-4. PubMed ID: 21109300
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
    Chung HH, Kang SY, Ha S, Kim JW, Park NH, Song YS, Cheon GJ.
    J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
    [Abstract] [Full Text] [Related]

  • 3. Standardized uptake value and metabolic tumor volume measured by ¹⁸F FDG PET/CT are sensitive biomarkers for the presence of lymph node metastasis in patients with cervical carcinoma.
    Vural GU, Akkas BE, Demirel BB.
    Rev Esp Med Nucl Imagen Mol; 2014 Mar; 33(5):268-73. PubMed ID: 25018135
    [Abstract] [Full Text] [Related]

  • 4. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
    Shim SH, Kim DY, Lee DY, Lee SW, Park JY, Lee JJ, Kim JH, Kim YM, Kim YT, Nam JH.
    BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
    [Abstract] [Full Text] [Related]

  • 5. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
    Sun Y, Lu P, Yu L.
    Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 May; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 7. Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer.
    Chung HH, Cheon GJ, Kang KW, Kim JW, Park NH, Song YS.
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):674-81. PubMed ID: 24233005
    [Abstract] [Full Text] [Related]

  • 8. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
    Hong JH, Min KJ, Lee JK, So KA, Jung US, Kim S, Eo JS.
    Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
    Ryu IS, Kim JS, Roh JL, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma.
    Lee HJ, Lee JJ, Park JY, Kim JH, Kim YM, Kim YT, Nam JH.
    J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634
    [Abstract] [Full Text] [Related]

  • 11. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, Abu-Rustum NR, Hricak H, Sala E.
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
    Crivellaro C, Signorelli M, Guerra L, De Ponti E, Buda A, Dolci C, Pirovano C, Todde S, Fruscio R, Messa C.
    Gynecol Oncol; 2012 Oct; 127(1):131-5. PubMed ID: 22772064
    [Abstract] [Full Text] [Related]

  • 13. Prospective evaluation of qualitative and quantitative ¹⁸F-FDG PET-CT parameters for predicting survival in recurrent carcinoma of the cervix.
    Maharjan S, Sharma P, Patel CD, Sharma DN, Dhull VS, Jain SK, Thulkar S, Malhotra A, Kumar R.
    Nucl Med Commun; 2013 Aug; 34(8):741-8. PubMed ID: 23676840
    [Abstract] [Full Text] [Related]

  • 14. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS.
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [Abstract] [Full Text] [Related]

  • 15. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG, Breuneval T, Prior JO, Bourhis J, Ozsahin M.
    Radiat Oncol; 2016 Mar 16; 11():43. PubMed ID: 26984385
    [Abstract] [Full Text] [Related]

  • 16. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
    Kidd EA, Siegel BA, Dehdashti F, Grigsby PW.
    Cancer; 2010 Mar 15; 116(6):1469-75. PubMed ID: 20108309
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
    Hong JH, Jung US, Min KJ, Lee JK, Kim S, Eo JS.
    Nucl Med Commun; 2016 Aug 15; 37(8):843-8. PubMed ID: 27058362
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
    Chung HH, Lee I, Kim HS, Kim JW, Park NH, Song YS, Cheon GJ.
    Gynecol Oncol; 2013 Sep 15; 130(3):446-51. PubMed ID: 23791826
    [Abstract] [Full Text] [Related]

  • 19. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
    Chang S, Kim SJ.
    Cancer Biother Radiopharm; 2016 Feb 15; 31(1):1-6. PubMed ID: 26844846
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S, Penney BC, Zhang H, Suzuki K, Pu Y.
    Acad Radiol; 2012 Jan 15; 19(1):69-77. PubMed ID: 22142679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.